triazoles has been researched along with Cancer of Cervix in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Cao, P; Chen, S; Cui, Y; Duan, X; Fan, Y; Hou, J; Kuang, Y; Ma, W; Tan, K; Xu, X; Zhou, N; Zhu, R; Zhu, Y | 1 |
Beltran, H; Demichelis, F; Rickman, DS; Rubin, MA | 1 |
Ávila-Ibarra, LR; de Lourdes Mora-García, M; Del Carmen Fuentes-Castañeda, M; Don-López, CA; García-Rocha, R; Gutiérrez-Serrano, V; Hernández-Montes, J; Monroy-García, A; Torres-Pineda, DB; Weiss-Steider, B | 1 |
Haedicke-Jarboui, J; Iftner, T; Rataj, O; Stubenrauch, F | 1 |
Bózsity, N; Mernyák, E; Minorics, R; Ocsovszki, I; Schneider, G; Szabó, J; Wang, HC; Wölfling, J; Wu, CC; Zupkó, I | 1 |
Kumaran, AP; Mishra, D; Paira, P; Sinha, S | 1 |
Douma, J; Kraayenbrink, AA; Lince, SL; Wiersma-Van Tilburg, AJ | 1 |
Augustin, E; Chambers, TC; Chu, R; Fedejko-Kap, B; Mazerska, Z; Pawlowska, M; Radominska-Pandya, A | 1 |
Chatterjee, NA; Das, K; Dobrowsky, W; Huilgol, NG; Kagiya, VT; Tatsuzaki, H | 1 |
Kammerer, S | 1 |
Dobrowsky, W; Huigol, NG; Jayatilake, RS; Kagiya, VT; Kizilbash, NI; Okkan, S; Tatsuzaki, H | 1 |
García-Angulo, AH; Kagiya, VT | 1 |
3 trial(s) available for triazoles and Cancer of Cervix
Article | Year |
---|---|
Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience.
Topics: Adult; Aged; Female; Humans; India; Middle Aged; Nervous System Diseases; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Triazoles; Uterine Cervical Neoplasms | 2002 |
AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
Topics: Adult; Aged; Brachytherapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Treatment Outcome; Triazoles; Uterine Cervical Neoplasms | 2007 |
Intratumoral and parametrial infusion of a 3-nitrotriazole (AK-2123) in the radiotherapy of the uterine cervix cancer: stage II-III--preliminary positive results.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Female; Humans; Radiation-Sensitizing Agents; Triazoles; Uterine Cervical Neoplasms | 1992 |
9 other study(ies) available for triazoles and Cancer of Cervix
Article | Year |
---|---|
Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
Topics: Animals; Benzoates; Deferasirox; Female; Humans; Iron; Iron Chelating Agents; Mice; Triazoles; Uterine Cervical Neoplasms | 2022 |
Biology and evolution of poorly differentiated neuroendocrine tumors.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azepines; Benzodiazepines; Carcinogenesis; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cell Differentiation; Cell Lineage; Cell Plasticity; Colonic Neoplasms; Disease Progression; Epigenesis, Genetic; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Neuroendocrine Tumors; Ovarian Neoplasms; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-myc; Pyrimidines; Retinoblastoma Binding Proteins; Triazoles; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 2017 |
Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
Topics: 5'-Nucleotidase; Acetamides; Adenosine; Adenosine A2 Receptor Antagonists; Autocrine Communication; Cell Line, Tumor; Female; GPI-Linked Proteins; HeLa Cells; Humans; Immunosuppression Therapy; Purines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Transforming Growth Factor beta1; Triazines; Triazoles; Tumor Microenvironment; Uterine Cervical Neoplasms | 2019 |
Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Topics: Antineoplastic Agents; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Human papillomavirus 16; Humans; Nuclear Proteins; Oncogene Proteins, Viral; Repressor Proteins; Transcription Factors; Triazoles; Uterine Cervical Neoplasms | 2019 |
Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Estrogen Receptor Modulators; Estrone; Female; Flow Cytometry; HeLa Cells; Human papillomavirus 16; Humans; Necrosis; Neoplasm Invasiveness; Prognosis; Triazoles; Tubulin; Uterine Cervical Neoplasms | 2017 |
Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Coumarins; Cycloaddition Reaction; Female; Fluorescent Dyes; HeLa Cells; Humans; MCF-7 Cells; Optical Imaging; Theranostic Nanomedicine; Triazoles; Uterine Cervical Neoplasms | 2016 |
Abnormal cervical smear: a sign of disseminated breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Letrozole; Middle Aged; Nitriles; Triazoles; Uterine Cervical Neoplasms; Vaginal Smears | 2008 |
Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.
Topics: Acridines; Aminoacridines; Antineoplastic Agents; Biotransformation; Cell Survival; Dose-Response Relationship, Drug; Female; Glucuronides; Glucuronosyltransferase; HeLa Cells; Humans; Inhibitory Concentration 50; Transfection; Triazoles; Uterine Cervical Neoplasms | 2013 |
[New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Topics: Adolescent; Adult; Age Factors; Anastrozole; Anticarcinogenic Agents; Breast Neoplasms; Celecoxib; Child; Double-Blind Method; Estrogen Antagonists; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Life Style; Mammography; Menarche; Menopause; Middle Aged; Nitriles; Ovariectomy; Pregnancy; Pyrazoles; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Sulfonamides; Tamoxifen; Triazoles; Uterine Cervical Neoplasms | 2003 |